Craig B Granowitz Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

Craig B Granowitz is SVP, Chief Medical Officer of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 120,252 shares of LXRX, which is worth approximately $39,683. The most recent transaction as insider was on Feb 28, 2025, when has been sold 65,308 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $43,756. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 120K

152.49% 3M change

152.49% 12M change

Total Value Held $39,683

Craig B Granowitz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	SELL Payment of exercise price or tax liability	$43,756 $0.67 p/Share	65,308 Reduced 35.2%	120,252 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	137,934 Added 42.64%	185,560 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$81,914 $2.62 p/Share	31,265 Reduced 39.63%	47,626 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	63,706 Added 44.68%	78,891 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$27,628 $2.17 p/Share	12,732 Reduced 45.61%	15,185 Common Stock
Feb 28 2023	BUY Exercise of conversion of derivative security	-	27,917 Added 50.0%	27,917 Common Stock

CBG

Craig B Granowitz

SVP, Chief Medical Officer

The Woodlands, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX

Account